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Background: Obesity is a major global health concern associated with multiple co-morbidities. Bariatric surgery has
been considered a good treatment option in cases of morbid obesity. This preliminary study aims to investigate the
effect of bariatric surgery on ovarian stimulation characteristics and IVF treatment cycle outcome.
Methods: A retrospective study that was performed in a tertiary, university-affiliated medical center and included all
patients who underwent IVF treatment both before and after bariatric surgery. Data on ovarian stimulation variables
of IVF treatment cycle prior and following the bariatric surgery were reviewed and compared.
Results: From January 2005 to June 2014, seven women fulfilled the inclusion criteria. After the operation, BMI was
significantly reduced (mean ± SD) (43.1 ± 3.3 vs. 29.6 ± 7.33, p = 0.018), as was the number of gonadotropin ampoules
required during stimulation (69.3 ± 10.5 vs. 44.5 ± 17, p = 0.043). No between-cycle differences were observed in peak
estradiol level, the number of oocytes retrieved, and percentage of mature oocytes.
Conclusions: To the best of our knowledge, this preliminary case series is the first comparison of IVF cycle
characteristics prior to and following bariatric surgery. The operation seems to reduce treatment costs without
affecting oocyte or embryo quality. Further large studies are required to establish the surgery’s effect on IVF
outcome among infertile women.
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Obesity is a major global health concern with increasing
prevalence [1]. According to the National Health and
Nutrition Examination Survey (NHANES), the preva-
lence of obesity [body mass index (BMI) > 30 kg/m2] in
the United States between 2011 and 2012 was as high as
36.1% among adult women, with a 8.3% prevalence of
morbid obesity (BMI ≥ 40) [2]. Obesity may be associated
with various co-morbidities such as diabetes type 2,
chronic hypertension, heart disease, sleep apnea, and
stroke [3]. Moreover, being obese may reduce woman’s
fertility, increase risks associated with pregnancy [4], and
be detrimental to in vitro fertilization (IVF) outcomes [5-8].
Treatment options include lifestyle modification, exer-
cise, dietary and pharmacological therapy, liposuction, and
bariatric surgery. While non-surgical approaches are gen-
erally associated with modest weight loss that is poorly* Correspondence: Ronit.Machtinger@sheba.health.gov.il
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unless otherwise stated.sustained in most patients, bariatric surgery has been
associated with significant weight loss, and its beneficial
effects seem to be sustained in the long term [9].
Along the many merits of bariatric surgeries, these
procedures might be followed by intraoperative, short
and long term complications as wound infection, leakage
through staples or sutures, abdominal hernia, ulcers,
dumping syndrome, and nutritional deficiencies leading
to anemia and osteoporosis [10].
Current indications for this operation are BMI ≥
40 kg/m2 without co-morbidities or BMI ≥ 35 kg/m2
with severe co-morbidities [11,12]. Bariatric surgeries are
classified as either mal-absorptive or restrictive [13] and
are effective in reducing obesity-associated co-morbidities
such as chronic hypertension and diabetes [13,14] and in
improving spontaneous fecundity and pregnancy outcome
[15]. However, data regarding the effects of bariatric sur-
gery on the reproductive outcome of infertile women
undergoing IVF are still scarce.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Tsur et al. Journal of Ovarian Research 2014, 7:116 Page 2 of 5
http://www.ovarianresearch.com/content/7/1/116Prompted by the aforementioned observations, we aimed
to investigate the effect of bariatric surgery on ovarian
stimulation characteristics and IVF treatment cycle out-
come in infertile patients undergoing IVF treatment, both
prior to and following bariatric surgery.Methods
The study population consisted of all female patients
admitted to our department between January 2005 and
June 2014 with a history of bariatric surgery. We in-
cluded only patients who underwent IVF treatment
cycles both prior to and following bariatric surgery.
The study was approved by the institutional IRB of
Sheba Medical Center. Stimulation protocols employed
for induction of follicular growth were previously described
[16] and included long GnRH agonist protocol, flare
GnRH-agonist protocol and the multidose GnRH antag-
onist protocol. Gonadotropines used included either
recombinant FSH or HMG.
Data on patient age, BMI, and variables related to in-
fertility treatment were collected from the files. Ovarian
stimulation characteristics, number of oocytes retrieved,
embryo quality, and number of embryos transferred during
the patients’ IVF cycles before and after bariatric surgery
were compared. Embryo classification was based on the
individual scoring parameters according to pre-established
definitions [17]. A top-quality embryo (TQE) was defined
as seven or more blastomeres on day 3, equal sized blasto-
meres, and <20% fragmentation; all other embryos were











# 1 Before 38 39.3 66 11 3025
After 40 29.8 66 11 2562
# 2 Before 36 42.7 50 11 4302
After 42 25.6 40 11 4346
# 3 Before 43 42 78 13 4167
After 44 37.6 66 11 1065
# 4 Before 26 47.8 71.5 25 1374
After 27 38.9 30 10 4826
# 5 Before 32 45.8 72 12 1158
After 35 33 32 8 5444
# 6 Before 29 39.1 * * *
After 31 20.7 * * *
# 7 Before 35 45.2 78 19 4271
After 39 21.5 33 13 4451.6
*Data missing.Statistical analysis was performed using Wilcoxon rank
sum test and Chi square, as appropriate p < 0.05 was
considered significant.Results
Out of 9869 patients treated in our IVF unit during the
study period, 18 had a history of bariatric surgery. Seven
such patients underwent an IVF treatment cycle both
before and after bariatric surgery. Five patients underwent
sleeve gastrectomy and two gastric banding. Mean patient
age ± SD at IVF cycles before and after the operation were
34.1 ± 5.69 years and 36.8 ± 6.1 years respectively. Reasons
for IVF included male factor infertility (n = 2), PCOS
(n = 2), genetic (n = 1), unexplained (n = 1) and age (n = 1).
Mean ± SD intervals between the operation and the subse-
quent IVF treatment cycle and between the consecutive
IVF cycles were 15.6 ± 7.9 months and 28.4 ± 29.0 months
respectively. All the patients had their weight stabilized
before starting the IVF treatment, as the metabolic param-
eters vary widely during the rapid weight-loss phase after
the surgery. Of the seven patients, following the operation
two had a normal BMI, two were overweight and three
remained obese (of them two remained morbid obese).
The clinical characteristics of patients’ IVF cycles before
and after the bariatric surgery are shown in Tables 1
and 2. BMI was significantly reduced after the operation
(43.1 ± 3.3 vs. 29.6 ± 7.33, p = 0.018). Moreover, in two
women severe co-morbidities (diabetes and hypertension)
completely resolved following bariatric surgery without
















6 3 0 2 Sleeve gastrectomy
4 4 0 4
19 14 6 2 Sleeve gastrectomy
9 9 1 3
2 2 1 2 Sleeve gastrectomy
1 1 0 1
Retrieval cancelled – lack of ovarian response Gastric banding
13 8 1 1
7 5 1 4 Sleeve gastrectomy
10 8 3 3
15 10 * 2 Gastric banding
20 16 3 4
12 12 0 3 Sleeve gastrectomy
8 8 3 2
Table 2 Summary of IVF treatment cycle characteristics of
all patients undergoing IVF: last cycle before and first
cycle after bariatric surgery
Before surgery After surgery p
BMI
Mean ±SD 43.1±3.3 29.6±7.3 0.018
Median 42.7 29.8
Range 39.1-47.8 20.7-38.9
Total number of gonadotropin
ampoules used








Mean ±SD 3049.5±1462.6 3782.4±1642.5 0.46
Median 3596 4398.8
Range 1158-4302 1065.0-5444.0
Number of follicles ≥15 mm
on day of hCG administration
Mean ±SD 3.8±2.3 7.0±4.2 0.1
Median 3 8
Range 2-8 1-11
Number of oocytes retrieved
Mean ±SD 10.1±6.3 8.7±6.5 0.6
Median 9.5 9
Range 2-19 1-20
Number of MII oocytes
Mean ±SD 7.7±5.0 7.7±5.0 1.0
Median 7.5 8
Range 2-14 1-16
%MII of all oocytes retrieved
Mean ±SD 79%±21.3 90.9±11.5 0.1
Median 74 100
Range 50-100 76-100
Fertilization rate (%) 71.7%±21.5 67.9±26.5%
Median 78.6 50
Range 50-100 44-100 0.46
Number of top-quality
embryos
Mean ±SD 1.6±2.5 1.6±1.3 0.78
Median 1 1
Range 0-6 0-3
Table 2 Summary of IVF treatment cycle characteristics of
all patients undergoing IVF: last cycle before and first
cycle after bariatric surgery (Continued)
% of top-quality embryos





Mean ±SD 2.5±0.8 2.8±1.1 0.51
Median 2 3
Range 2-4 1-4
Number of embryos frozen
Mean ±SD 1.8±2.0 0.8±1.6 0.28
Median 1.5 1.5
Range 0-4 0-4
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fewer gonadotropin ampoules. There were no differences
between the cycles in peak estradiol level, number of fol-
licles ≥15 mm on day of hCG administration, the number
of oocytes retrieved, MII oocytes, fertilization rates or
number of TQE.
One of the patients conceived from embryos cryopre-
served in the cycle following the operation. This preg-
nancy ended in missed abortion in the first trimester.
Other patients did not conceive in the first cycle after the
surgery.
Discussion
In this preliminary case series we observed a significant
decrease in the total number of gonadotropin ampoules
required during IVF cycle following bariatric surgery, with
no adverse effects on the number of follicles ≥15 mm,
number of oocytes retrieved and number of MII oocytes.
To the best of our knowledge, this is the first comparison
of IVF cycle characteristics prior to and following bariatric
surgery. To date, few reports have described treatment out-
comes of infertile female patients undergoing IVF following
bariatric surgery. Doblado et al. published their description
of five patients who underwent IVF treatment following
bariatric surgery [18]. All their patients conceived in
the first or second IVF cycle following the operation, and
none experienced complications during or after IVF treat-
ment cycles. The authors concluded that bariatric surgery
is a safe procedure in women undergoing artificial repro-
duction techniques. Christofolini et al. compared ovarian
stimulation parameters and treatment outcome among
three different groups of patients: (a) 29 patients after bar-
iatric surgery [average BMI 26.6 kg/m2, range (22.8-35.8)];
(b) 57 obese patients [average BMI 32.8 kg/m2, range (30.1-
46.2)]; and (c) 94 normal-BMI and overweight patients
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their first IVF cycle [19]. They reported significantly fewer
follicles, oocytes retrieved, and mature oocytes among
patients with a prior bariatric surgery as compared with
patients from the two other groups. Although the dif-
ference was statistically significant, it seems clinically
meaningless, since the mean number of follicles and
oocytes retrieved were 5 and 5 (respectively) in the bar-
iatric surgery group, 6 and 6 in the obese group, and 7
and 6.5 in the normal BMI/overweight group. However,
their conclusions might deserve further consideration,
as the difference might be attributable to the variability
in ovarian reserve parameters among patients rather
than the intervention.
The effect of bariatric surgery on female fertility and
ovarian reserve is of specific significance, given the
reported increase in the number of bariatric surgeries
[20]. Therefore, evaluating the effects of this operation
on female fertility has become quite relevant. Radical
decreases in BMI after the operation have previously
been described. The significant decrease in the number
of FSH ampoules required after the surgery is associated
both with reduced treatment costs and increased patient
comfort, due to fewer injections.
Moreover, while the radical decrease in weight following
surgery usually improves metabolic impairments such as
diabetes, it might also cause deficiencies in iron, folate,
vitamin B12, calcium, and vitamin D [21]. Animal and
human data suggest that these nutrients might play a role
in folliculogenesis and oocyte maturation [22-24], with
deficiencies possibly causing detrimental effects on fertility.
Time to start treatment again was tailored by patient’s
age, weight reduction and metabolic parameters. Possibly
some of the beneficial effects of bariatric surgery on fertil-
ity were obscured by the time passed and the potential
decrease in ovarian reserve due to aging. Historically
women undergoing bariatric surgery were advised to delay
pregnancy for 12 to 24 months after surgery. This recom-
mendation was intended to both optimize weight loss
and minimize adverse effects of nutritional deficiencies
[25,26]. Recent studies and guidelines emphasize the
importance of nutritional balance rather than the time
from surgery to conception [27]. It might make sense
to offer this treatment option to younger patients, seek-
ing for infertility treatments, as in the older population
the delay in time might interfere with fertility treatment
results.
The main limitations of our study are the small sample
size (seven patients) and the long period between the
operation and the subsequent IVF treatments. In order
to demonstrate, for example, a difference of 30% in the
number of oocytes retrieved at a power of 80% and an
alpha value of 5% using the uncorrected chi-squared
test, 33 study subjects would be needed. This is apreliminary study and the sample size was limited by the
unique methodology comparing IVF cycle characteristics
in the same patients prior to and following bariatric
surgery and the relative rarity of such patients.
Conclusions
These preliminary case series suggest that bariatric surgery
for weight reduction seems to be a safe and beneficial
treatment option for morbidly obese infertile patients.
Further studies are needed to evaluate the long-term
effects of bariatric surgery on ovarian reserve or ovar-
ian stimulation characteristics.
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